We investigated doxorubicin (DOX)-loaded nanospheres (NS) formulated using a biodegradable polymer, poly(D,L-lactide-co-glycolide) (PLGA), for targeted chemotherapy of brain tumours. A nonionic surfactant, polysorbate 80 (P80), was used to modify the surfaces of PLGA NS to improve cellular drug delivery. DOX-loaded PLGA NS were formulated by emulsion solvent diffusion and characterised for DOX encapsulation and in vitro release. The effectiveness of DOX-loaded P80–PLGA NS was investigated in A172 human glioblastoma cells. The drug release pattern was dependent on the pH of the medium. Quantitatively, the cellular uptake of NS was significantly increased by P80 surface modification compared with unmodified NS. Confocal laser scanning microscopy studies revealed that DOX was released from NS following accumulation in the cell nuclei. DOX-loaded P80–PLGA NS could significantly inhibit both DOX efflux from the cells and cell proliferation compared with a DOX solution.
Preparation method of polymeric micelles based on polyvinyl caprolactam–polyvinyl acetate–polyethylene glycol graft copolymer (Soluplus®) have been successfully established as nanocarriers for a drug delivery system on a biofilm formed by Staphylococcus epidermidis. The biodegradable poly(DL-lactide-co-glycolide) (PLGA) nanoparticles were also prepared for comparison. To design effective nanocarriers against biofilm infections, we tested the four types of polymeric nanocarriers on the biofilm: unmodified PLGA, PLGA modified with chitosan (CS), unmodified Soluplus® micelles (Sol), and Sol modified with CS. The antibacterial activity of each nanocarrier against the biofilm was evaluated using field emission scanning electron microscopy (FE-SEM) with hydrophilic ionic liquid (IL) and confocal laser scanning microscopy. FE-SEM results revealed the exact morphology of carriers and bacterial cells at the nanoscale level by an optimized method using IL. The nanocarriers adhering to the biofilm were quantified using the phenol–sulfuric acid method. Antibacterial activity of nanocarriers was determined by minimum inhibitory concentration and minimum bactericidal concentration, and antibacterial assay using LIVE/DEAD BacLight bacterial viability kit. The highest antibacterial activity against the biofilm was demonstrated by a prepared Sol modified with CS. This nanocarrier would be useful for curing biofilm infections. In addition, visualization of the antibacterial activity at the nanoscale level could help in designing effective nanocarriers for target agents.
1 January 1991 in Chemical and Pharmaceutical Bulletin
In order to mask the bitter taste of drugs, a novel microencapsulation process combined with the wet spherical agglomeration (WSA) technique was developed by using a modified phase separation method. The spherical agglomerates of enoxacin (ENX) with various additives including disintegrants were successfully produced in the system of acetone-n-hexane-ammonia water or acetone-n-hexane-distilled water by the WSA, using flocculation phenomena of particles in liquid. Resultant agglomerates could be microencapsulated continuously with Eudragit RS utilizing the phase separation method in the same system as agglomeration under stirring. 'Explosible' microcapsules which were free from the bitter taste could be produced in formulating finer particle size of ENX and 50 per cent of Primojel in core agglomerates, using distilled water as a bridging liquid, and treating with 20 per cent polymer coating level. These microcapsules were bioequivalent to the commercial ENX 100 mg tablets in beagle dogs. One continuous process technique of agglomeration and microencapsulation was useful for the design of ENX powders which masked the bitter taste and controlled the drug release rate.